Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in PGEN — Precigen, Inc.

CIK 1387508 NEW YORK, NY

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,028,921
+$113,816 QoQ
Shares Held
882,267
-30.5% QoQ
Ownership
0.246%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#26
of 210 holders
Holding Since
Jun 2020
8 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Derivatives in PGEN

reported options exposure · as of Jun 30, 2026
CallValue
$927,390
CallShares
162,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $43,640,056 across 72 Biotechnology names. PGEN ranks #3 (11.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 PGEN
Precigen, Inc.
This page
882,267 $5,028,921

All Filings in PGEN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,028,921 882,267
2026-06-30 $927,390 162,700
2026-03-31 $4,915,105 1,270,053
2025-12-31 $2,716,891 649,974
2025-09-30 $886,691 269,511
2025-06-30 $186,147 131,090
2023-12-31 $21,966 16,393
2020-09-30 $2,450 700
2020-09-30 $350 100
2020-06-30 $7,485 1,500
2020-06-30 $499 100